Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection
about
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisRifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysisControl of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural MalawiDrug resistance profiles of Mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of CameroonAnti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national surveyFeasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyEvaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, UgandaPrevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia.The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.Relatively low primary drug resistant tuberculosis in southwestern EthiopiaImplementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda.Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study.A single-nucleotide-polymorphism real-time PCR assay for genotyping of Mycobacterium tuberculosis complex in peri-urban Kampala.Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human TuberculosisPrimary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.Whole genome sequencing to complement tuberculosis drug resistance surveys in UgandaImpact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosisEpidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.Mycobacterium tuberculosis in central Ethiopia: drug sensitivity patterns and association with genotype.The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda.Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
P2860
Q28477855-2D1421A2-B52F-4099-8E9D-8AA5F3E000DCQ28480467-B01F6A04-D985-46BF-9362-36789B6C6510Q28487692-3B02ED2D-1BFF-4A10-A6EB-9147889E3E9FQ28534467-628D0D25-02CF-45CE-8E57-EA33705CBA6DQ28535035-C8D957F4-38AB-469C-9FD3-4DF72FEDDB75Q29615717-60AF9971-7C30-4A65-85B8-FF652C526814Q31088965-5D70B2A9-0E49-437C-A443-55798D40EC78Q33562852-2B219810-4B64-441F-AEBC-AD142E3F634AQ33798212-EAC76D9E-3D22-4A20-B403-241B3DA03187Q34265158-EB6E0BF0-B2ED-4C28-A82F-62A0960209E9Q34895110-37C29A1B-B2B4-4862-A708-7B280B0297DAQ35030196-BCD280CE-BE06-4EFB-A929-10307EB8915BQ35059462-4F003E88-3FFB-468C-9570-D725DD93851AQ35546001-CEA44268-ECB7-430E-9181-715824A0A2FDQ35621974-BF19C449-FC3B-4A23-8F52-E3C90D715019Q35794156-EC4BFADA-F38D-443B-9CC7-B90B720973CDQ35993510-5A24C097-4F2A-4392-8670-BA408758715BQ36080613-E8B4A623-FB4B-4B4C-B163-259C8CD32944Q36869848-CE5777F1-7F09-46FF-BFA0-3CC9F7CA96A4Q37162231-4164B17C-EF1A-4F55-A683-28D114DD7965Q37423406-FC05F65C-3B59-432E-BD98-42C29E6628ECQ37702101-A2609A8E-F76B-481F-9C9A-452C01D664FCQ37725239-34E89CFB-DDA8-4846-B257-E655BA21B97FQ39120260-9AC06F55-8DE0-43F3-87C5-42DF88132A4DQ41633888-9591DA92-8052-4B5F-9FA9-7B1B86559BD5Q41930740-3AA10277-CB74-47C1-B7C6-F0A8838E2EFEQ55260133-4E85A9C8-305A-4856-B46C-02C757725B8F
P2860
Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rates of anti-tuberculosis dru ...... associated with HIV infection
@ast
Rates of anti-tuberculosis dru ...... associated with HIV infection
@en
Rates of anti-tuberculosis dru ...... associated with HIV infection
@nl
type
label
Rates of anti-tuberculosis dru ...... associated with HIV infection
@ast
Rates of anti-tuberculosis dru ...... associated with HIV infection
@en
Rates of anti-tuberculosis dru ...... associated with HIV infection
@nl
prefLabel
Rates of anti-tuberculosis dru ...... associated with HIV infection
@ast
Rates of anti-tuberculosis dru ...... associated with HIV infection
@en
Rates of anti-tuberculosis dru ...... associated with HIV infection
@nl
P2093
P2860
P3181
P1433
P1476
Rates of anti-tuberculosis dru ...... associated with HIV infection
@en
P2093
Francis E Adatu
Frank G J Cobelens
Fred Nuwaha
Joseph K Lule
Nicholas Ezati
Samuel Kirimunda
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016130
P407
P577
2011-01-10T00:00:00Z